Podracka Ludmila, Feber Janusz, Lepage Nathalie, Filler Guido
Department of Pediatrics, Children's Hospital of Eastern Ontario, University of Ottawa, Ottawa, Ontario, Canada.
Pediatr Transplant. 2005 Feb;9(1):28-32. doi: 10.1111/j.1399-3046.2005.00235.x.
There is controversy about the feasibility of cystatin C (CysC) as a marker of glomerular filtration rate (GFR) post-transplant (Tx). We studied intra-patient variability of CysC in comparison with serum creatinine (SCr) in 20 children (11 males, mean age 11.5 +/- 6.4 yr) with solid organ transplants (14 kidney, four liver, and two combined liver + kidney transplants). The mean age at Tx was 7.0 +/- 5.6 yr. A total of 178 simultaneous SCr and CysC measurements (median 8 per patient) were analyzed. In addition, GFR was calculated using the Schwartz and a novel CysC-based formula. Intra-individual coefficient of variations (CV) was calculated as ratio of standard deviation over mean. The mean CV was significantly lower for SCr (7.71 +/- 4.16%) when compared with CysC (10.27 +/- 4.87, p = 0.04), but was no longer significantly different when excluding patients with a bladder augment. The CV of the GFR estimated by Schwartz formula (7.44 +/- 3.77) was significantly lower than GFR calculated from CysC (12.52 +/- 7.37), p = 0.001. The mean ratio between the Schwartz GFR and the GFR calculated from CysC was 102.6 +/- 12.8%, not significantly different from 100% (p = 0.3796). The only potential confounding factors to explain increased CV after Tx were gender and bladder augmentation, whereas calcineurin inhibitors or steroids did not influence CV. With the limitation of a small number of subjects, our data suggest that the CysC and the CysC-calculated GFR is equivalent but not better than SCr and Schwartz formula. We therefore conclude that measurement of CysC can be used for longitudinal intra-individual follow-up of renal function post-Tx.
胱抑素C(CysC)作为移植后肾小球滤过率(GFR)指标的可行性存在争议。我们研究了20名接受实体器官移植的儿童(11名男性,平均年龄11.5±6.4岁,其中14例肾移植、4例肝移植、2例肝肾联合移植)CysC与血清肌酐(SCr)的患者内变异性。移植时的平均年龄为7.0±5.6岁。共分析了178次同时进行的SCr和CysC测量值(每位患者中位数为8次)。此外,使用Schwartz公式和基于CysC的新公式计算GFR。个体内变异系数(CV)计算为标准差与平均值之比。与CysC(10.27±4.87,p = 0.04)相比,SCr的平均CV(7.71±4.16%)显著更低,但排除膀胱扩大患者后差异不再显著。Schwartz公式估算的GFR的CV(7.44±3.77)显著低于根据CysC计算的GFR(12.52±7.37),p = 0.001。Schwartz GFR与根据CysC计算的GFR的平均比值为102.6±12.8%,与100%无显著差异(p = 0.3796)。解释移植后CV增加的唯一潜在混杂因素是性别和膀胱扩大,而钙调神经磷酸酶抑制剂或类固醇不影响CV。由于受试者数量有限,我们的数据表明CysC及基于CysC计算的GFR与SCr和Schwartz公式等效,但并不优于它们。因此,我们得出结论,CysC测量可用于移植后肾功能的纵向个体内随访。